Possible mechanisms include constitutive activation of upstream signaling pathways, e.g. by BCR-ABL or inactivation of PTEN as shown in T-ALL lines, activating mutations of NOTCH1, RAS, or of the PI3K itself as in B-lymphomas [43–45]. This evidence concerns the gene PTEN and acute lymphoblastic leukemia.